GLP-4TE Active Phase 2 by DesBio

GLP-4TE Active Phase 2 continues the multi-pathway signaling work of Phase 1 through the 1M and 10M ascending potency sequence — supporting ongoing communication across appetite, satiety, insulin, leptin, and central neuroendocrine networks as patients progress toward their weight goal.

Phase 1 activates the signaling environment. Phase 2 deepens it — supporting continued metabolic signaling, appetite regulation, and emotional identity shift as patients progress further toward their weight goal.

Phase 2 continues the same non-stimulant, non-suppression approach — supporting the body's own appetite, satiety, and metabolic regulatory signals at the deeper 1M and 10M potency levels.

Phase 2 addresses what clinicians encounter mid-protocol: patients with more weight to lose, shifting emotional terrain, and nutritional needs that extend beyond the Phase 1 timeline.

• Supports continued appetite and satiety signaling pathways
• Assists ongoing metabolic adaptation during active weight change
• Supports neuroendocrine communication related to energy balance
• Supports identity and esteem shifts accompanying continued weight change
• Supports preservation of lean tissue during continued caloric recalibration